|
gptkbp:instance_of
|
gptkb:Antihero
|
|
gptkbp:age_group
|
6 years and older
|
|
gptkbp:approves
|
gptkb:1995
gptkb:FDA
|
|
gptkbp:available_in
|
various strengths
|
|
gptkbp:available_on
|
gptkb:pharmaceuticals
gptkb:Sugar
liquid gel
dissolving tablet
|
|
gptkbp:brand
|
gptkb:Zyrtec-D
Zyrtec Allergy
Zyrtec Chewables
Zyrtec Liquid
|
|
gptkbp:clinical_trial
|
studied for efficacy
studied for safety
studied for long-term use
|
|
gptkbp:clinical_use
|
seasonal allergies
itching from hives
perennial allergies
|
|
gptkbp:contraindication
|
severe renal impairment
|
|
gptkbp:dosage_form
|
oral
10 mg once daily
1 tablet daily
2.5 mg for children 2-5 years
5 mg once daily for children
|
|
gptkbp:formulation
|
gptkb:tablet
gptkb:liquid
chewable tablet
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Zyrtec
|
|
gptkbp:ingredients
|
cetirizine
|
|
gptkbp:interacts_with
|
gptkb:beer
CNS depressants
|
|
gptkbp:invention
|
gptkb:2015
|
|
gptkbp:manufacturer
|
gptkb:Johnson_&_Johnson
|
|
gptkbp:marketed_as
|
gptkb:Europe
gptkb:Australia
gptkb:Canada
gptkb:United_States
|
|
gptkbp:previous_name
|
cetirizine hydrochloride
|
|
gptkbp:safety
|
Category B
|
|
gptkbp:side_effect
|
fatigue
headache
nausea
abdominal pain
vomiting
diarrhea
drowsiness
insomnia
dry mouth
palpitations
|
|
gptkbp:storage
|
room temperature
|
|
gptkbp:used_for
|
hives
allergic rhinitis
|
|
gptkbp:bfsParent
|
gptkb:Pfizer_Consumer_Healthcare
gptkb:JNJ
gptkb:Super_Bowl_XXXII
gptkb:Vicks
|
|
gptkbp:bfsLayer
|
5
|